Has Kaitlin Gaffney, NP received payments from drug or device companies?

Yes. Drug and device makers reported $1,237 in general payments to Kaitlin Gaffney, NP across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kaitlin Gaffney, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kaitlin Gaffney, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kaitlin Gaffney, NP

Psychiatric/Mental Health · Needham, MANPI 1437527728

Payments from drug & device makers

$1,237in general payments, 2019–2025

Across 60 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$393
Otsuka America Pharmaceutical, Inc.$136
Supernus Pharmaceuticals, Inc.$119
Alkermes, Inc.$102
Sunovion Pharmaceuticals Inc.$97
Axsome Therapeutics, Inc.$77
plus $312 from 9 others

What the payments were for

Food & beverage$1,237100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	22	$393
Otsuka America Pharmaceutical, Inc.	5	$136
Supernus Pharmaceuticals, Inc.	5	$119
Alkermes, Inc.	4	$102
Sunovion Pharmaceuticals Inc.	6	$97
Axsome Therapeutics, Inc.	3	$77
Neurocrine Biosciences, Inc.	3	$70
Corium, LLC	3	$60
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Collegium Pharmaceutical, Inc.	2	$40
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$34
E.r. Squibb & Sons, L.L.C.	1	$21
Lundbeck LLC	1	$16
Tempus AI, Inc	1	$15
Bausch Health US, LLC	1	$14

How this compares

$1,237 in reported general payments places this provider in the 80th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$15,078

Medicare patients

Services billed

148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lamotrigine	43	$519
Quetiapine Fumarate	14	$228
Buspirone Hcl	21	$197
Aripiprazole	11	$174
Bupropion XlBupropion Hcl	15	$158
Lorazepam	36	$138
Mirtazapine	21	$130
Bupropion Hcl SrBupropion Hcl	19	$121
Fluoxetine Hcl	31	$96
Trazodone Hcl	11	$85
Escitalopram Oxalate	14	$70
Lithium Carbonate	25	$62

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Needham

Brianne LienkampMarion$121K
Ashley BakerQuincy$54K
Brian BanksPembroke$47K
Anne-Margaret BotelhoMattapoisett$46K
Matthew PeculisWalpole$41K
Sherrie UrenaWorcester$21K
Irina DauphineeHanover$18K
Schree PettigrewNew Bedford$18K
Sherryl RosenLynn$16K
Kevin NardoneWorcester$16K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →